Mode
Text Size
Log in / Sign up

Naringenin shows strong antidepressant-like effects in rat meta-analysisCitrus compound shows antidepressant effects in rats

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret these preclinical findings cautiously; naringenin shows antidepressant-like effects in rats, but human data are lacking.

This meta-analysis of 13 preclinical studies involving 212 rats evaluated the antidepressant-like effects of naringenin compared to control groups. The primary outcomes included immobility time in the forced swimming test (FST) and tail suspension test (TST), as well as number of crossings in the open field test (OFT) and sucrose consumption.

Naringenin significantly reduced immobility time in the FST (SMD = -4.66; 95% CI -6.55 to -2.76; P < 0.00001) and TST (SMD = -5.36; 95% CI -7.37 to -3.36; P < 0.0001). It also increased the number of crossings in the OFT (SMD = 2.18; 95% CI 0.52 to 3.85; P = 0.01) and elevated sucrose consumption (SMD = 4.18; 95% CI 2.66 to 5.71).

The authors acknowledge that this is a preclinical study only, and animal model results do not directly translate to human clinical outcomes. Safety and tolerability data were not reported. The certainty of evidence was not reported.

These findings are preliminary and require further investigation in clinical trials before any practice relevance can be established.

How this fits prior evidence

This meta-analysis of preclinical studies adds to prior coverage on depression by exploring a novel intervention in animal models. Prior coverage noted high depression prevalence (50.9%) in advanced cancer patients and associations with air pollution, but did not address naringenin. This study extends the evidence base by suggesting potential antidepressant-like effects in rats, though it does not address human clinical outcomes or the diagnostic or intervention gaps highlighted in prior coverage.

A natural compound found in citrus fruits might one day help treat depression. But so far, the evidence comes only from rats.

Researchers analyzed 13 studies involving 212 rats. They found that naringenin, a flavonoid in grapefruit and oranges, significantly reduced depression-like behaviors. In the forced swimming test, rats given naringenin spent less time immobile, a sign of less despair. The effect was large, with a statistical measure of -4.66. Similar results were seen in the tail suspension test, with an effect of -5.36.

The compound also increased activity in the open field test and boosted sucrose consumption, which suggests improved pleasure response. All results were statistically significant.

But here's the catch: these are animal studies. What works in rats may not work in humans. The researchers did not report any side effects or safety data. So while the findings are promising, they are very early. Human clinical trials are needed before anyone should consider naringenin for depression.

What this means for you:
Naringenin shows promise for depression in rats, but human studies are needed.

Common questions

What is naringenin?

Naringenin is a natural compound found in citrus fruits like grapefruit and oranges. It belongs to a class of plant chemicals called flavonoids. In this study, researchers tested its effects on depression-like behaviors in rats.

Does naringenin work for depression in humans?

Not yet. This study was done only in rats, not people. The results are promising but very early. We need human clinical trials to know if naringenin is safe and effective for depression in humans.

How was the effect measured in the study?

The researchers used several tests. In the forced swimming test and tail suspension test, they measured how long rats stayed immobile. Less immobility suggests less depression. They also measured activity in an open field and how much sugar water the rats drank, which indicates pleasure.

Were there any side effects?

The study did not report any side effects or safety information. Since this was a preclinical study in rats, safety data is not yet available. Human studies would need to carefully monitor for side effects.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BackgroundThe prevalence of depression has increased steadily over recent decades, making it a major global public health concern. Although currently available pharmacotherapies demonstrate therapeutic efficacy, their clinical utility is often limited by adverse effects. Naringenin, a naturally occurring flavonoid compound, has shown potential antidepressant-like effects in preclinical studies. However, no comprehensive meta-analysis has yet systematically evaluated its efficacy in animal models of depression.ObjectiveThis study aimed to systematically assess the antidepressant-like effects of naringenin in animal models of depression through a systematic review and meta-analysis, and to further elucidate its underlying mechanisms of action.MethodsA systematic literature search was conducted across five electronic databases (Embase, Web of Science, PubMed, Cochrane Library, and OVID) from database inception to November 2025. Methodological quality was assessed using the SYRCLE risk of bias tool. Data synthesis and statistical analyses were performed using Review Manager 5.4.ResultsA total of 13 studies involving 212 rats were included. Meta-analysis demonstrated that, compared with the control group, naringenin treatment significantly reduced immobility time in the forced swimming test (FST)[SMD = −4.66; 95% CI (−6.55, −2.76); P < 0.00001] and tail suspension test (TST) [SMD = −5.36; 95% CI (−7.37, −3.36); P < 0.0001], increased the number of crossings in the open field test (OFT) [SMD = 2.18; 95% CI (0.52, 3.85); P= 0.01], and elevated sucrose consumption [SMD = 4.18; 95% CI (2.66, 5.71); P
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.